Entrada Therapeutics
TRDA
TRDA
52 hedge funds and large institutions have $361M invested in Entrada Therapeutics in 2023 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
8% more capital invested
Capital invested by funds: $334M → $361M (+$26.9M)
3.45% less ownership
Funds ownership: 78.69% → 75.24% (-3.4%)
Holders
52
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$2.28M | |
| 2 | +$1.23M | |
| 3 | +$861K | |
| 4 |
CA
CHI Advisors
New York
|
+$817K |
| 5 |
HF
HRT Financial
New York
|
+$556K |
Top Sellers
| 1 | -$5.15M | |
| 2 | -$442K | |
| 3 | -$326K | |
| 4 |
E
Ergoteles
New York
|
-$190K |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$164K |